Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0113 Transporter Info | ||||
Gene Name | SLC16A9 | ||||
Transporter Name | Monocarboxylate transporter 9 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
CEBPD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein delta | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein delta (CEBPD) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
MAX |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [4] | ||||
TF Protein Name |
Protein max | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Breast; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein max (MAX) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in glioblastoma multiforme condition | [5] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLC16A9 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in breast cancer condition | [6] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Estrogen receptor (ESR1) has been reported to bind to the SLC16A9 gene in breast cancer condition, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in health condition | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC16A9 gene in health condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [3] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in erythroleukemia condition | [8] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC16A9 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [4] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in prostate cancer condition | [9] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC16A9 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in health condition | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC16A9 gene in health condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
FOXM1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A9 gene in breast cancer condition | [10] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) has been reported to activate the transcription of SLC16A9 gene in breast cancer condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 9. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [1] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A9 gene in colorectal cancer condition | [11] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC16A9 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 9. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in glioblastoma multiforme condition | [5] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to bind to the transcription of SLC16A9 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A9 gene | [2] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC16A9 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 9. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A9 gene in epithelial ovarian cancer condition | [12] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC16A9 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.